Limbic
PrivateLast Round
Series A
Mar 5, 2024
Total Funding Raised
$16.75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Limbic operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in March 2024.
Limbic is a clinical artificial intelligence company that develops AI-powered tools for mental healthcare, including patient intake, triage, and therapy support platforms.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical AI, Patient Engagement, NLP & Conversational AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limbic Comparables
Compare Limbic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wysa | 76% | |
| Woebot Health | 74% | |
| Upheal | 72% |
For institutional investors. Book with your work email.
Limbic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2024 | ||||
| Seed | Nov 24, 2021 | ||||
| Grant | May 1, 2020 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Jan 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Limbic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Khosla Ventures | Series A |
| European Commission | Seed |
| Gaingels | Series A |
| 7 Percent Ventures | Seed |
| Innovate UK | Seed |
| Joyance Partners | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 18% QoQ, from 57 to 67 employees.
- Apr 1, 2026
Launching new 'AI therapist' product for end-to-end care in the US.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 24, 2026
Limbic is to offer Unpacked, a clinician-supervised AI mental health service that provides cognitive behavioral therapy by telephone for eligible Medicare beneficiaries with anxiety or depression, as part of the FDA’s TEMPO pilot in the United Kingdom.
For institutional investors. Book with your work email.
Limbic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Limbic's valuation, stock price, and market status.
Is Limbic a public or private company?
Limbic is a private company.
What is the current stock price of Limbic?
Limbic is a private company, so its shares have no public market price. Caplight tracks Limbic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Limbic worth (valuation)?
Valuation information for Limbic is not publicly available.
Can I buy Limbic stock?
Limbic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Limbic's last funding round?
Limbic's most recent funding round was Series A on March 5, 2024.
Who are the main investors in Limbic?
Key investors in Limbic include Khosla Ventures.
Will Limbic IPO soon?
No public IPO plans have been announced for Limbic.
How can I track Limbic secondary market activity?
Caplight tracks bids, offers, and trades in Limbic's shares on secondary markets.